References
- Cwik VA. ALS clinical motor signs and symptoms. Mitsumoto H, Przedborski S, Gordon PH. Amyotrophic Lateral Sclerosis. New York: Taylor & Francis Group, 2006. 99–116.
- Chad DA. Classification, diagnosis and presentation of diagnosis of ALS. Mitsumoto H, Przedborski S, Gordon PH. Amyotrophic Lateral Sclerosis. New York: Taylor & Francis Group, 2006. 201–26.
- Finsterer J. Neuromuscular implications in CADASIL. Cerebrovasc Dis. 2007;24:401.
- Wang T, Baron M, Trump D. An overview of Notch3 function in vascular smooth muscle cells. Prog Biophys Mol Biol. 2008;96:499–509.
- Brooks BR, Miller RG, Swash M, Munsat TL. World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:239–93.
- Singhal S, Rich P, Markus HS. The spatial distribution of MR imaging abnormalities in cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy and their relationship to age and clinical features. AJNR Am J Neuroradiol. 2005;26:2481–7.
- Joutel A, Andreux F, Gaulis S, Domenga V, Cecillon M, Battail N, . The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Invest. 2000;105:597–605.
- Dichgans M, Mayer M, Uttner I, Brüning R, Müller-Höcker J, Rungger G, . The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol. 1998;44: 731–9.
- Pescini F, Bianchi S, Salvadori E, Poggesi A, Dotti MT, Federico A, . A pathogenic mutation on exon 21 of the Notch3 gene causing CADASIL in an octogenarian pauci-symptomatic patient. J Neurol Sci. 2008;267:170–3.
- Zhong Z, Deane R, Ali Z, Parisi M, Shapovalov Y, O'Banion MK, . ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat Neurosci. 2008;11:420–2.
- Paubel A, Violette J, Amy M, Praline J, Meininger V, Camu W, . Mutations of the ANG gene in French patients with sporadic amyotrophic lateral sclerosis. Arch Neurol. 2008; 65:1333–6.
- Greenway MJ, Andersen PM, Russ C, Ennis S, Cashman S, Donaghy C, . ANG mutations segregate with familial and sporadic amyotrophic lateral sclerosis. Nat Genet. 2006;38:411–3.
- Kieran DM, Greenway MJ, Hardiman O, Prehn J. The effects of angiogenin on motor neuron degeneration. Amyotrophic Lateral Sclerosis. 2005;6(Suppl 1):42.
- Xu ZP, Tsuji T, Riordan JF, Hu GF. The nuclear function of angiogenin in endothelial cells is related to rRNA production. Biochem Biophys Res Commun. 2002;294: 287–92.
- Corcia P, Camu W, Halimi JM, Vourc'h P, Antar C, Vedrine S, . SMN1 gene, but not SMN2, is a risk factor for sporadic ALS. Neurology. 2006;67:1147–50.
- Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, . TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668–72.
- Vance C, Rogelj B, Hortobágyi T, de Vos KJ, Nishimura AL, Sreedharan J, . Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208–11.